fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Prof. Orvieto – a renowned scientific journal editor

Prof. Orvieto an expert in IVF
The director of Sheba’s IVF Unit, Prof. Raoul Orvieto, has been appointed editor in chief of the prestigious international journal Reproductive Biology & Endocrinology. The IVF unit at Sheba is renowned for its expert treatment of both female and male fertility issues and offers a wide range of advanced therapies

Prof. Raoul Orvieto, Director of the IVF Unit, Division of Obstetrics and Gynecology at Sheba Medical Center, was appointed Editor in Chief of Reproductive Biology & Endocrinology, a prestigious international journal with a 2.1 impact factor.

The journal focuses on the endocrinology and biology of reproduction. Sheba’s IVF Unit is recognized as one of the leading IVF programs in the country. The Unit’s team offers unparalleled experience in all areas of reproductive medicine, including the most advanced and effective treatments for infertility.

Not surprisingly, couples from all around the world travel to Sheba for fertility treatment. The Unit focuses on aspects of female infertility including mechanical, hormonal, endometriosis, and idiopathic infertility.

It also specializes in the treatment of male infertility factors such as surgical repair of varicoceles, electrostimulation ejaculation, and epididymal and testicular sperm retrieval for use in IVF and ICSI. The unit also offers techniques for embryo pre-implantation genetic diagnosis (PGD) and fertility preservation treatments

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More